Long-acting Insulin, Mealtime Insulin Management, Fast-acting Pen-based Insulin, And Oral Diabetes Medications

The recent FDA approval of Afrezza, an inhaled insulin, could open up new options in mealtime insulin management for type 1 and type 2 diabetics, reports Health Day.
After being up for approval two previous times, the drug has now passed safety inspections that indicate Afrezza’s efficacy and safet…